Hypoxic incubator for physiological cell culture research
用于生理细胞培养研究的低氧培养箱
基本信息
- 批准号:10427609
- 负责人:
- 金额:$ 10.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2023-09-19
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAnti-Inflammatory AgentsAntigen PresentationAutoimmunityCancer BiologyCarbon DioxideCell Culture TechniquesCell CycleCellsDiabetes MellitusFundingHumidityHypoxiaImmunologyIncubatorsInstitutionInvestigationMalignant NeoplasmsMedicineMetabolismMonitorOutputOxygenPhysiologicalRadiation OncologyRequest for ProposalsResearchResearch PersonnelRoleSamplingSupervisionTemperatureTissuesUnited States National Institutes of Healthatmospheric conditionsbiological systemscancer therapyimmunogenicinstrumentinstrumentationmitochondrial dysfunctionpleiotropismprogramsradiation effecttranscription factortumor
项目摘要
SUMMARY
This proposal requests funds to acquire a hypoxic incubator and workstation in one, which provides precise
control of temperature, humidity, oxygen and carbon dioxide levels. Oxygen levels can be controlled in 0.1%
increments from 0.1% to 20%, thus encompassing the various levels found in tissues, including in tumors which
often are extremely hypoxic with levels ranging between 0.3 and 2.0% oxygen. This application will directly
support 6 NIH-funded investigators and 3 young investigators currently applying for NIH funding. Each of these
investigators has specific projects that benefits from the unique aspects of the HypOxystation® H35 workstation.
Cells that are under low oxygen tension accumulate and activate hypoxia-inducible transcription factor alpha-
subunits HIF-1a and HIF-2a, leading to pleiotropic effects including modulating cellular metabolism, cell cycle
and anti-inflammatory activities. Availability of this instrument will enable crucial investigations of the role of
hypoxia in modulating the immunogenic effects of radiation, antigen presentation in cancer and diabetes, and
mitochondrial dysfunction in autoimmunity. Unique features of the HypOxystation® H35, including a large
workspace, sample input/output port, sleeve ports and precise environmental control and monitoring produce
stable atmospheric conditions for culturing and manipulating samples, which is required for carrying out rigorous
research into the role of oxygen tension within a biological system. The HypOxystation® H35 will provide
capabilities to Weill Cornell Medicine and neighboring institutions and will be supervised by an advisory
committee, overseen by the Radiation Oncology department, and will thus positively impact basic and
translational NIH-funded research. The NIH-funded research programs supported by this instrumentation have
relevance to cancer biology and treatment, immunology, metabolism, and autoimmunity.
总结
该提案要求提供资金来购买集缺氧培养箱和工作站于一体的设备,以提供精确的
温度、湿度、氧气和二氧化碳水平的控制。氧气含量可控制在0.1%
增量为0.1%至20%,因此涵盖了组织中发现的各种水平,包括
通常极度缺氧,氧含量在0.3%到2.0%之间。该应用程序将直接
支持6名NIH资助的研究人员和3名正在申请NIH资助的年轻研究人员。这一切成功都
研究人员有特定的项目,受益于HypOxystation® H35工作站的独特方面。
细胞在低氧张力下积累并激活低氧诱导转录因子α-
HIF-1a和HIF-2a亚基,导致多效性作用,包括调节细胞代谢、细胞周期
和抗炎活性。这一工具的可用性将使关键的调查的作用,
低氧在调节辐射的免疫原性作用、癌症和糖尿病中的抗原呈递,以及
自身免疫中的线粒体功能障碍。HypOxystation® H35的独特功能,包括
工作空间、样品输入/输出端口、套筒端口和精确的环境控制和监测
培养和操作样品的稳定大气条件,这是进行严格的
研究氧张力在生物系统中的作用。HypOxystation® H35将提供
威尔康奈尔医学和邻近机构的能力,并将由一个顾问监督
委员会,由放射肿瘤科监督,因此将积极影响基本和
转化NIH资助的研究。由NIH资助的研究项目得到了这种仪器的支持,
与癌症生物学和治疗、免疫学、代谢和自身免疫相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sandra Demaria其他文献
Sandra Demaria的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sandra Demaria', 18)}}的其他基金
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
分段放射激活癌细胞内源性干扰素-I 通路
- 批准号:
9207065 - 财政年份:2016
- 资助金额:
$ 10.45万 - 项目类别:
Individualized in situ vaccination by radiation and immunotherapy
通过放射和免疫治疗进行个体化原位疫苗接种
- 批准号:
9127533 - 财政年份:2016
- 资助金额:
$ 10.45万 - 项目类别:
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
分段放射激活癌细胞内源性干扰素-I 通路
- 批准号:
9009692 - 财政年份:2016
- 资助金额:
$ 10.45万 - 项目类别:
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
分段放射激活癌细胞内源性干扰素-I 通路
- 批准号:
10366757 - 财政年份:2016
- 资助金额:
$ 10.45万 - 项目类别:
Individualized in situ vaccination by radiation and immunotherapy
通过放射和免疫治疗进行个体化原位疫苗接种
- 批准号:
9904135 - 财政年份:2016
- 资助金额:
$ 10.45万 - 项目类别:
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
分段放射激活癌细胞内源性干扰素-I 通路
- 批准号:
10706961 - 财政年份:2016
- 资助金额:
$ 10.45万 - 项目类别:
Local Radiation as an Adjuvant for Immunotherapy
局部放射作为免疫治疗的辅助剂
- 批准号:
7263431 - 财政年份:2007
- 资助金额:
$ 10.45万 - 项目类别:
Local Radiation as an Adjuvant for Immunotherapy
局部放射作为免疫治疗的辅助剂
- 批准号:
7760656 - 财政年份:2007
- 资助金额:
$ 10.45万 - 项目类别:
Local Radiation as an Adjuvant for Immunotherapy
局部放射作为免疫治疗的辅助剂
- 批准号:
7383133 - 财政年份:2007
- 资助金额:
$ 10.45万 - 项目类别:
Local Radiation as an Adjuvant for Immunotherapy
局部放射作为免疫治疗的辅助剂
- 批准号:
8020091 - 财政年份:2007
- 资助金额:
$ 10.45万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 10.45万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 10.45万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 10.45万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 10.45万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 10.45万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 10.45万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 10.45万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 10.45万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 10.45万 - 项目类别:














{{item.name}}会员




